SAP Helps Simplify Personalized Medicine to Fight Cancer and Other Illnesses

SAPSAP SE (NYSE: SAP) has announced an expanded commitment and significant progress in its effort to make the benefits of personalized medicine available to more patients fighting cancer and other serious illnesses.

"We're focused on improving people’s lives with simple solutions to complex problems, and we recognize that the most universally relevant challenges are in healthcare," said Martin Kopp, vice president and head of the global healthcare industry unit, SAP. "Co-innovating with partners of all sizes on our technology platforms, we’re working across the board to improve health and make a rapid, direct impact on quality of life."

Transforming Cancer Care
The American Society for Clinical Oncology recently announced that its wholly owned subsidiary, CancerLinQ LLC, has chosen the SAP HANA platform for the development of ASCO's CancerLinQ™. CancerLinQ is intended to be a groundbreaking health information technology (HIT) platform that will harness Big Data to deliver high-quality care to patients with cancer. It is one of the only major cancer data initiatives being developed and led by physicians with the primary purpose of improving patient care.

"CancerLinQ is the kind of innovation needed to advance the vision of precision medicine," said Dr. Peter Paul Yu, MD, president, ASCO. "By collecting and analyzing data from almost every U.S. cancer patient, CancerLinQ is intended to uncover personalized insights that will benefit oncology practices and patients across the United States - no matter what their affiliation or choice of electronic health record systems may be - and accelerate medical advances."

SAP also announced in June 2014 that it will offer a personalized treatment recommendation service to its employees fighting cancer. The service, called COPE (Corporate Oncology Program for Employees) and offered through a partnership with MOLECULAR HEALTH GmbH, delivers decision support for targeted cancer treatments, aiming for better results with fewer side effects.

The ASCO relationship builds on last year’s early deployment of Medical Research Insights, a service based on an oncology clinical data platform that SAP developed in partnership with the German National Center for Tumor Diseases (NCT) and now in use for testing purposes at its facilities in Heidelberg, Germany. At this time, Medical Research Insights is intended for use in medical research only and not the treatment of patients.

The COPE service will initially be used for the benefit of SAP employees with a cancer diagnosis. In the spirit of SAP's mission of making the world run better, it is SAP’s hope that providing this service will create a standard that will be adopted by other employers. The service has already been made available for employees in the United States and Germany, with the intent for employees in additional countries to gain from this benefit in the near future.

Enabling Targeted Care with Analytics
In another example, Dartmouth-Hitchcock health system (D-H) is working with analytics solutions from SAP and the SAP HANA platform to help predict surgical outcomes for its patients experiencing chronic knee pain. The initiative, named GreenCare, is aimed at improving the patient care experience by allowing physicians to help improve surgical outcomes, address costs and help avoid unnecessary surgeries. GreenCare combines real-time data analytics with patient-focused, science-based surveys to give patients the best outcomes.

Making Sense of Big Data
To deliver highly targeted care, research and healthcare organizations need technology that gathers and shares very large volumes and varieties of health data and information. PHEMI, an SAP partner that offers an enterprise-grade Big Data warehouse, supports healthcare organizations with a solution that helps researchers and clinicians find the information they need quickly and easily.

"Healthcare organizations are transforming unprecedented volumes and types of data into medical insights," said David Delaney, chief medical officer, SAP (Americas). "The challenge isn't just to gather the information, but to organize it and make it available to researchers across the country or around the globe and at the same time enforce data sharing and consent agreements."

Related news articles:

About SAP
As market leader in enterprise application software, SAP (NYSE: SAP) helps companies of all sizes and industries run better. From back office to boardroom, warehouse to storefront, desktop to mobile device - SAP empowers people and organizations to work together more efficiently and use business insight more effectively to stay ahead of the competition. SAP applications and services enable more than 282,000 customers to operate profitably, adapt continuously and grow sustainably.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...